Tag: anetumab ravtansine

Bayer antibody-drug conjulate (ADC) misses in phase 2 mesothelioma trial

Bayer's antibody-drug conjulate (ADC) anetumab ravtansine has failed to show improvements in the survival rates of mesothelioma patients. Stock prices of Bayer's collaborators ImmunoGen...

Popular

Zenia Boulevard Lights Up November with Christmas Events and Black Friday Promotions

The Zenia Boulevard Shopping Centre in Alicante is set...

Altet Breaks Record with 15.8 Million Passengers in 10 Months

Alicante-Elche Miguel Hernández Airport has set a new annual...

Orihuela Costa planning still takes a back seat to construction

By Peter Houghton Tuesday, October 29th, 2024, will go down...

Pilar garbage rate will increase more on the coast

Pilar de la Horadada is increasing its garbage tax...